Ultralife (Nasdaq:ULBI) - Aktienkurs, Nachrichten und Analyse

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

ULBI Aktienübersicht

Die Ultralife Corporation und ihre Tochtergesellschaften entwickeln, produzieren, installieren und warten weltweit Energie-, Kommunikations- und Elektroniksysteme.

Über das Unternehmen

ULBI fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Belohnungen

Das Kurs-Gewinn-Verhältnis (17.8x) liegt unter dem Branchendurchschnitt Electrical (21.9x)

In diesem Jahr profitabel geworden

Risikoanalyse

Die Erträge sind in den letzten 5 Jahren um 45.7% pro Jahr zurückgegangen

Die Aktionäre wurden im vergangenen Jahr verwässert

Volatiler Aktienkurs in den letzten 3 Monaten

Ultralife Corporation Wettbewerber

Zeo Energy

NasdaqCM:ZEO

US$192.3m

Allient

NasdaqGM:ALNT

US$449.1m

LSI Industries

NasdaqGS:LYTS

US$431.2m

CBAK Energy Technology

NasdaqCM:CBAT

US$139.4m

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Ultralife
Historical stock prices
Current Share Price	US$11.46
52 Week High	US$13.39
52 Week Low	US$4.26
Beta	1.13
1 Month Change	-4.26%
3 Month Change	18.14%
1 Year Change	150.22%
3 Year Change	23.36%
5 Year Change	45.06%
Change since IPO	-13.51%

Aktuelle Nachrichten und Updates

Ultralife Corporation: Ready To Surge

Apr 22

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Apr 16

Recent updates

Ultralife Corporation: Ready To Surge

Apr 22

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Apr 16

Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For Excitement

Mar 14

We Think Ultralife Corporation's (NASDAQ:ULBI) CEO Compensation Package Needs To Be Put Under A Microscope

Jul 15

Is Ultralife Corporation (NASDAQ:ULBI) Potentially Undervalued?

Apr 14

The Trends At Ultralife (NASDAQ:ULBI) That You Should Know About

Mar 09

Ultralife Corporation's (NASDAQ:ULBI) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 18

Ultralife reports Q4 results

Feb 04

If You Had Bought Ultralife (NASDAQ:ULBI) Stock Five Years Ago, You Could Pocket A 17% Gain Today

Feb 03

What Type Of Shareholders Make Up Ultralife Corporation's (NASDAQ:ULBI) Share Registry?

Jan 14

Are Insiders Buying Ultralife Corporation (NASDAQ:ULBI) Stock?

Dec 30

Is Ultralife (NASDAQ:ULBI) Using Too Much Debt?

Dec 15

Has Ultralife (NASDAQ:ULBI) Got What It Takes To Become A Multi-Bagger?

Dec 02

A Look At Ultralife's (NASDAQ:ULBI) CEO Remuneration

Nov 19

Ultralife reports Q3 results

Oct 29

Aktionärsrenditen

	ULBI	US Electrical	US Markt
7D	1.4%	-1.9%	-1.2%
1Y	150.2%	29.8%	21.5%

Rendite im Vergleich zur Industrie: ULBI übertraf die Branche US Electrical, die im vergangenen Jahr eine Rendite von 35.9 erzielte.

Rendite vs. Markt: ULBI übertraf den Markt US, der im vergangenen Jahr eine Rendite von 25.6 erzielte.

Preisvolatilität

Is ULBI's price volatile compared to industry and market?
ULBI volatility
ULBI Average Weekly Movement	10.8%
Electrical Industry Average Movement	10.3%
Market Average Movement	5.8%
10% most volatile stocks in US Market	15.6%
10% least volatile stocks in US Market	2.9%

Stabiler Aktienkurs: ULBIDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: ULBIDie wöchentliche Volatilität (11%) war im letzten Jahr stabil, liegt aber immer noch höher als bei 75 % der US Aktien.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1990	536	Michael Manna	www.ultralifecorporation.com

Die Ultralife Corporation und ihre Tochtergesellschaften entwickeln, produzieren, installieren und warten weltweit Energie-, Kommunikations- und Elektroniksysteme. Das Unternehmen ist in zwei Segmenten tätig: Battery & Energy Products und Communications Systems. Das Segment Battery & Energy Products bietet 9-Volt-Lithiumbatterien, zylindrische Batterien, dünne Lithium-Mangandioxid-Batterien, wiederaufladbare und andere nicht wiederaufladbare Batterien, Lithium-Ionen-Zellen, Lithium-Ionen-Batteriesysteme mit Multi-Kilowatt-Modulen und unterbrechungsfreie Stromversorgungen sowie robuste militärische und kommerzielle Batterieladesysteme und Zubehör, einschließlich intelligenter Ladegeräte, Multi-Bay-Ladesysteme und verschiedener Kabel.

Ultralife Corporation's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Ultralife im Vergleich zum Marktanteil des Unternehmens?
ULBI grundlegende Statistiken
Marktanteil	US$190.49m
Gewinn(TTM)	US$10.43m
Umsatz(TTM)	US$168.66m

18.3x

Kurs-Gewinn-Verhältnis

1.1x

Kurs-Umsatz-Verhältnis

Ist ULBI zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
ULBI Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$168.66m
Kosten der Einnahmen	US$125.42m
Bruttogewinn	US$43.23m
Sonstige Ausgaben	US$32.80m
Umsatz	US$10.43m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	0.63
Bruttomarge	25.63%
Nettogewinnspanne	6.19%
Schulden/Eigenkapital-Verhältnis	19.5%

Wie hat sich ULBI auf lange Sicht entwickelt?

Historische Performance und Vergleiche

ULBI Aktienübersicht

Belohnungen

Risikoanalyse

Ultralife Corporation Wettbewerber

NasdaqCM:ZEO

US$192.3m

NasdaqGM:ALNT

US$449.1m

NasdaqGS:LYTS

US$431.2m

NasdaqCM:CBAT

US$139.4m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Investor sentiment improves as stock rises 17%

Price target decreased by 7.7% to US$12.00

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Ultralife Corporation: Ready To Surge

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024

Recent updates

Investor sentiment improves as stock rises 17%

Price target decreased by 7.7% to US$12.00

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Ultralife Corporation: Ready To Surge

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For Excitement

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Investor sentiment improves as stock rises 15%

Insufficient Growth At Ultralife Corporation (NASDAQ:ULBI) Hampers Share Price

New major risk - Revenue and earnings growth

Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024

Independent Chairman recently bought US$111k worth of stock

Independent Chairman recently bought US$181k worth of stock

Independent Chairman recently bought US$99k worth of stock

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Is Now An Opportune Moment To Examine Ultralife Corporation (NASDAQ:ULBI)?

Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023

Investor sentiment improves as stock rises 18%

Ultralife (NASDAQ:ULBI) May Have Issues Allocating Its Capital

Independent Chairman recently bought US$112k worth of stock

Investor sentiment improves as stock rises 27%

Consensus revenue estimates increase by 12%

New major risk - Share price stability

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023

Independent Chairman recently bought US$398k worth of stock

Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of Debt

Independent Chairman recently bought US$146k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 19, 2023

Independent Chairman recently bought US$117k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought US$122k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought US$279k worth of stock

Ultralife Corporation Announces Executive Changes

Price target increased to US$12.00

Insufficient new directors

Third quarter 2022 earnings: EPS misses analyst expectations

Ultralife Corporation to Report Q3, 2022 Results on Oct 27, 2022

Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of Debt

Ultralife secures $7.5M communications systems contract

Independent Chairman recently bought US$158k worth of stock

Independent Chairman recently bought US$467k worth of stock

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ultralife receives $4.6M communications systems VAA order

Ultralife Corporation to Report Q2, 2022 Results on Jul 28, 2022

Independent Chairman recently bought US$219k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 20, 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Insufficient new directors

Ultralife Corporation to Report Q1, 2022 Results on Apr 28, 2022

Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet?

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Chairman recently bought US$245k worth of stock

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates fall by 14%

Erträge & Einnahmen